Oral News and Research

RSS

Seniors cite financial need as the greatest barrier to receiving dental care

A survey of seniors' access to dental care conducted by researchers at the University at Buffalo and Buffalo State College presents a sobering picture of the dental needs and barriers to dental care experienced by seniors.

11 Apr 2006

Salivary biomarkers of existing periodontal disease

A University of Kentucky study published in the Journal of American Dental Association could help change the diagnosis and treatment of periodontal disease.

11 Apr 2006

Thermal injury induced insulin resistance is associated with the renin-angiotensin system

Researchers have found a way to prevent insulin resistance in burn-injured rats, a finding that, while still quite preliminary, could eventually save burn victims' lives and speed their recovery.

6 Apr 2006

Link between bacteria found in the mouth and the amniotic fluid of a woman in preterm labor

A 37-year-old-mother, who gave birth to a low-weight preemie at 24 weeks, exhibited the first-found link in a human between bacteria found in the mouth and the amniotic fluid of a woman in preterm labor.

6 Apr 2006

Antioxidant therapy will be useful for women with pre-eclampsia

The antioxidant tempol prevents the onset of pre-eclampsia in pregnant mice, a finding that further implicates oxidative stress in the illness, which is widespread among pregnant women.

4 Apr 2006

Life or death can depend on teenage cancer patients taking their treatments properly

Teenagers and young adults with cancer need to understand the implications of not taking their treatments regularly, at the right time, and for the whole course. Those who don't are seriously compromising their future health - and for some it will be the difference between life and death.

4 Apr 2006

Few young Americans tested for common STD's

New data indicate the average age of people who are tested for chlamydia, the most reported sexually transmitted disease (STD), is 28.9 for women and 30.5 for men, yet the Centers for Disease Control and Prevention (CDC) reports 79 percent of new infections annually are in people between ages 15 and 24.

28 Mar 2006

Sodium hyaluronate shown to help chronic shoulder pain

After the rise in safety concerns surrounding Vioxx and other Cox-2 inhibitors, people suffering from chronic shoulder pain were left with just two therapy options at opposite extremes - take Advil, or have surgery.

28 Mar 2006

Asthma drug approved for children age four up

The U.S. Food and Drug Administration (FDA) has given approval for the use of the asthma drug Flovent HFA in children four to eleven years of age.

26 Mar 2006

Raloxifene shows potential benefits in treating prostate cancer

In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer.

23 Mar 2006

Breast symmetry can be early indicator of breast cancer

Healthy Women who go on to develop breast cancer tend to have less symmetrical breasts than those women who do not develop the disease, researchers at the University of Liverpool have found.

21 Mar 2006

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

The patent which is assigned to the University of Pittsburgh has been exclusively licensed to PRP. The drug, known as PulmoLAR, containing 2ME as active ingredient, is currently developed by PRP for the treatment of pulmonary arterial hypertension (PAH).

21 Mar 2006

Finasteride combined with oral contraceptives may improve female hair loss

Finasteride, a medication approved to treat hair loss in men, may also improve the condition in women when combined with oral contraceptives, according to an article in the March issue of Archives of Dermatology.

21 Mar 2006

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

EntreMed has announced the issuance of U.S. Patent No. 7,012,070 covering methods of treatment for a broad range of indications with its lead clinical-stage compound, 2-methoxyestradiol (2ME2).

17 Mar 2006

African American women urged to confront colorectal cancer

Despite having the greatest risk of developing and dying from colorectal cancer (CRC) of any gender, race or ethnicity, an astounding 96 percent of African American women do not consider themselves to be at high risk for the disease, according to a new Harris poll.

17 Mar 2006

Impact of a scientific presentation on community treatment patterns for primary breast cancer

The oral presentation of data from a single study at a national scientific conference can have an important impact on patient treatment, even before study publication or Food and Drug Administration (FDA) approval

15 Mar 2006

Clopidogrel reduces risk of adverse events for patients with acute coronary syndromes undergoing balloon angioplasty

Patients with acute coronary syndromes who were pre-treated with the anti-platelet agent clopidogrel before undergoing a procedure such as balloon angioplasty or stent placement had a reduced risk of adverse events if they received the anti-clotting drug abciximab

14 Mar 2006

Single dose of oral antibiotic azithromycin taken after trichiasis eye surgery prevents recurrence of inturned eyelashes

A Johns Hopkins Medicine study finds that a single dose of the oral antibiotic azithromycin taken after trichiasis eye surgery can reduce the frequency with which eyelashes turn back in and abrade the eye.

14 Mar 2006

Low pressure and low oxygen factors in DVT and long flights

Researchers say that the risk of deep vein thrombosis (DVT) during flights may not be due simply to sitting still; they say the low pressure and low oxygen environment during air travel may also contribute to the development of deep vein thrombosis in some susceptible individuals.

13 Mar 2006

Study reveals mechanisms behind Thiazolidinediones used to treat type 2 diabetes

Thiazolidinediones (TZD's) are drugs commonly prescribed to patients with type 2 diabetes, the most common form of diabetes. Current U.S. Food and Drug Administration-approved agents are known as Actos (pioglitazone) and Avandia (rosiglitazone).

13 Mar 2006

Oral News and Research

Seniors cite financial need as the greatest barrier to receiving dental care

Salivary biomarkers of existing periodontal disease

Thermal injury induced insulin resistance is associated with the renin-angiotensin system

Link between bacteria found in the mouth and the amniotic fluid of a woman in preterm labor

Antioxidant therapy will be useful for women with pre-eclampsia

Life or death can depend on teenage cancer patients taking their treatments properly

Few young Americans tested for common STD's

Sodium hyaluronate shown to help chronic shoulder pain

Asthma drug approved for children age four up

Raloxifene shows potential benefits in treating prostate cancer

Breast symmetry can be early indicator of breast cancer

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

Finasteride combined with oral contraceptives may improve female hair loss

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

African American women urged to confront colorectal cancer

Impact of a scientific presentation on community treatment patterns for primary breast cancer

Clopidogrel reduces risk of adverse events for patients with acute coronary syndromes undergoing balloon angioplasty

Single dose of oral antibiotic azithromycin taken after trichiasis eye surgery prevents recurrence of inturned eyelashes

Low pressure and low oxygen factors in DVT and long flights

Study reveals mechanisms behind Thiazolidinediones used to treat type 2 diabetes

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News